NASDAQ : PNTG
The Pennant Group, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 41.66 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.46B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.41B |
| Enterprise Value | 1.89B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 34.93M |
| Shares Outstanding | 34.93M |
| Shares Change (YoY) | +3.65% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 4.95% |
| Owned by Institutions (%) | 92.56% |
| Float | 33.20M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 44.48 |
| Forward PE | 27.36 |
| PS Ratio | 1.29 |
| Forward PS | 1.16 |
| PB Ratio | 4.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 54.38 |
| P/OCF Ratio | 26.60 |
| PEG Ratio | 2.17 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 58.73 |
| EV / Sales | 1.72 |
| EV / EBITDA | 25.45 |
| EV / EBIT | 29.46 |
| EV / FCF | 72.81 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.20 |
| Quick Ratio | 0.97 |
| Debt / Equity | 1.23 |
| Debt / EBITDA | 3.60 |
| Debt / FCF | 19.01 |
| Interest Coverage | 6.03 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.42% |
| Return on Assets (ROA) | 4.50% |
| Return on Invested Capital (ROIC) | 5.47% |
| Return on Capital Employed (ROCE) | 7.28% |
| Weighted Average Cost of Capital (WACC) | 8.65% |
| Revenue Per Employee | $113,578 |
| Profits Per Employee | $3,332 |
| Employee Count | 9,700 |
| Asset Turnover | 1.23 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 14.14M |
| Effective Tax Rate | 26.89% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +63.77% |
| 50-Day Moving Average | 39.99 |
| 200-Day Moving Average | 35.49 |
| Relative Strength Index (RSI) | 47.38 |
| Average Volume (20 Days) | 318,419 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.15M |
| Short Previous Month | 1.18M |
| Short % of Shares Out | 3.29% |
| Short % of Float | 3.46% |
| Short Ratio (days to cover) | 2.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.10B |
| Gross Profit | 215.83M |
| Operating Income | 64.42M |
| Pretax Income | 52.60M |
| Net Income | 32.32M |
| EBITDA | 74.57M |
| EBIT | 64.42M |
| Earnings Per Share (EPS) | $0.91 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 15.27M |
| Total Debt | 495.55M |
| Net Cash | -480.28M |
| Net Cash Per Share | -$13.75 |
| Equity (Book Value) | 404.44M |
| Book Value Per Share | 10.24 |
| Working Capital | 31.19M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 53.31M |
| Capital Expenditures | -27.24M |
| Depreciation & Amortization | 10.15M |
| Net Borrowing | 161.50M |
| Free Cash Flow | 26.07M |
| FCF Per Share | $0.75 |
Margins
| Measure | Value |
|---|
| Gross Margin | 19.59% |
| Operating Margin | 5.85% |
| Pretax Margin | 4.77% |
| Profit Margin | 2.93% |
| EBITDA Margin | 6.77% |
| EBIT Margin | 5.85% |
| FCF Margin | 2.37% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.65% |
| Shareholder Yield | -3.65% |
| Earnings Yield | 2.25% |
| FCF Yield | 1.84% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $46.83 |
| Price Target Difference | 15.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 12.25% |
| EPS Growth Forecast (3Y) | 16.07% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.38 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |